V2 Swan Robotics
This catalogue entry combines two unrelated things. Its website, swanendosurgical.com, belongs to Swan EndoSurgical, an endoluminal surgical robotics company that Olympus and private equity firm Revival Healthcare Capital announced in July 2025, agreeing to jointly invest US$458 million. Swan is based in Boston with a technology centre in Cambridge, UK, and aims to deliver a fully integrated flexible robotic platform for complex gastrointestinal interventions. It enters and navigates the GI tract like an endoscope and deploys flexible robotic arms to treat lesions, tumours and other disease, and Erik Todd was appointed CEO. The hand listed here, InMoov Hand V2, is different: InMoov is an open-source, 3D-printable humanoid robot designed by French sculptor Gaël Langevin, which began in January 2012 as an open-source prosthetic hand that anyone can print on a home 3D printer.
💡Notable Achievement: Olympus and Revival Healthcare Capital agreed to jointly invest US$458 million in Swan EndoSurgical in July 2025.
What Does V2 Swan Robotics Do?
This entry mixes Swan EndoSurgical, an Olympus-backed GI surgical robotics start-up, with the open-source InMoov hand that begins the InMoov humanoid project.
“Two unrelated projects under one record.”
Swan EndoSurgical
Flexible endoluminal robot for GI surgery.
US$458 Million
Joint Olympus and Revival investment.
InMoov Hand
Open-source 3D-printable hand.
What Can V2 Swan Robotics Robots Actually Do?
Cross-portfolio operational capabilities, manipulation tasks, and environmental competencies
Surgical robotics and an open-source hand.
Open-Source Hand
InMoov hand printable on a home 3D printer.
V2 Swan Robotics Robots & Products
Showing 0 of 0 total models
V2 Swan Robotics Timeline & Milestones
Evolutionary history, landmark prototypes, major acquisitions, and commercial roadmap
InMoov project begins with an open-source hand
Gaël Langevin starts the InMoov project as the first open-source 3D-printed prosthetic hand, later growing into a full life-size humanoid robot.
Source: inmoov.fr
Olympus and Revival launch Swan EndoSurgical
Olympus and Revival Healthcare Capital announce Swan EndoSurgical, an endoluminal GI surgical robotics company backed by US$458 million of joint investment.
Source: olympus-global.com
V2 Swan Robotics Competitors by Category
Direct industry rivals grouped by specific robotics domain
What Makes V2 Swan Robotics Different?
Editorial AnalysisOrigin of Bots objective strategic assessment, engineering moats, and commercial hurdles
Key Strengths & Moats
- ✓Well-funded surgical start-up.
- ✓Widely used open-source hand design.
Core Strategic Focus
Developing the flexible GI robotic platform.
Road Ahead & Challenges
- •Catalogue record combines unrelated subjects.
- •Swan is pre-commercial.
Corporate Ecosystem & Ownership Structure
Parent company relationships, historical acquisitions, and global operating facilities
Olympus
Co-founded Swan EndoSurgical in 2025.
Ownership & Acquisition History
Co-founded Swan EndoSurgical in 2025.
Private equity partner in the venture.
Global Facilities & Operating Hubs
V2 Swan Robotics Headquarters
HQBoston, Massachusetts, United States
Frequently Asked Questions
8 AnswersVerified answers, company specifications, and deployment details about V2 Swan Robotics
What is Swan EndoSurgical?
Swan EndoSurgical is an endoluminal surgical robotics company founded by Olympus and Revival Healthcare Capital in 2025 to build a flexible robotic platform for gastrointestinal interventions.
How much was invested in Swan EndoSurgical?
Olympus and Revival Healthcare Capital agreed to jointly invest US$458 million in the venture, announced in July 2025. This catalogue entry combines two unrelated things.
Where is Swan EndoSurgical based?
Swan EndoSurgical is based in Boston, with a technology centre in Cambridge, United Kingdom. This catalogue entry combines two unrelated things. Its website, swanendosurgical.com, belongs to Swan EndoSurgical, an endoluminal surgical robotics company that Olympus and private equity firm Revival Healthcare Capital announced in July 2025, agreeing to jointly invest US$458 million.
Who is the CEO of Swan EndoSurgical?
Olympus announced that veteran robotics and medtech leader Erik Todd was appointed CEO of Swan EndoSurgical. This catalogue entry combines two unrelated things.
What will the Swan robot do?
It is planned to enter and navigate the GI tract like an endoscope while deploying flexible robotic arms to treat lesions, tumours and other diseases.
What is the InMoov Hand V2?
InMoov Hand V2 is a version of the open-source, 3D-printable hand from the InMoov humanoid robot project created by Gaël Langevin, printable on a home 3D printer.
What is InMoov?
InMoov is the first open-source 3D-printed life-size robot, created by French sculptor Gaël Langevin and started in January 2012 as an open-source prosthetic hand.
Why is this entry confusing?
The catalogue record mixes the InMoov open-source hand with the website of Swan EndoSurgical, so the hand and the surgical robotics company are unrelated.
Verified Data & Editorial Assurance
Compiled from verified corporate filings, official V2 Swan Robotics datasheets, and robotics engineering registries. Information has been verified against official manufacturer documentation. For commercial procurement or proprietary integrations, contact the manufacturer directly.